"I really started to understand that to have the most impactful experiment, you don’t have to have the perfect design. Science doesn’t always have to be beautiful or perfect. It’s even more important to be timely."
— Dr. Stanley Lee
/content/dam/www/people-profile-photos/l/stanley-lee/stanley-lee-d.jpg
Lee
Stanley Lee, PhD
- Associate Professor, Translational Science and Therapeutics Division, Fred Hutch
- Member, Immunotherapy Integrated Research Center (IIRC), Fred Hutch
- Member, Translational Data Science Integrated Research Center (TDS IRC), Fred Hutch
- Affiliate Investigator, Clinical Research Division, Fred Hutch
- Affiliate Investigator, Human Biology Division, Fred Hutch
Background
Dr. Stanley Lee studies the molecular basis of blood cell development and how its dysregulation can lead to hematologic malignancies such as myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). His research focuses on defining how disease-causing mutations impact the biology of hematopoietic stem and progenitor cells, and how they drive disease progression and response to therapy. The ultimate goal of Dr. Lee’s research is to translate this knowledge into novel treatments for patients with blood-related disorders including leukemia.
Education
Postdoctoral Fellowship, Memorial Sloan Kettering Cancer Center, 2014-2019
PhD, Walter and Eliza Hall Institute of Medical Research, 2012
MSc (Hons), University of Auckland, 2007
BSc (Hons), University of Auckland, 2005
Research Interests
Understanding and targeting altered RNA processing in hematologic malignancies
Epigenetic regulation of normal and malignant hematopoiesis
Identification and development of novel therapeutic approaches to hematologic malignancies